50
Participants
Start Date
November 30, 2015
Primary Completion Date
June 1, 2017
Study Completion Date
August 1, 2017
Poly-L-Lactic Acid (Sculptra) injection
1 vial of of poly-l-lactic acid (Sculptra) reconstituted in the usual sterile fashion with 7cc of sterile water and 2cc of Lidocaine without epinephrine. The contents of the vial will be injected as deemed appropriate by the certified injector and agreed upon by the study subject.
Collaborators (1)
Galderma R&D
INDUSTRY
Yardley Dermatology Associates
OTHER